A Community Bio-Tech Lab Offers a Crash Course in Designing Life — Open to the Public
By Adam Wernick,
PRI
| 06. 05. 2015
Untitled Document
“Scientists in general are awful at communicating their work to the general public,” says Jorgensen, the director of Genspace. “The consumer is already using genetically modified and genetically engineered products in their daily life. So, wouldn't it be nice if the end user were also someone who could have a say about what this technology was used for?“
Genspace, which opened in downtown Brooklyn in 2009, is the world's first community bio-lab. It offers a three-class crash course in synthetic biology to anyone who is interested. It also has a working lab space where the general public is invited to come in and learn how to do genetic science — hands on.
At Genspace, Wetherell experimented with her own DNA. Here her DNA is suspended in an agarose gel that is charged by an electical current that separates the proteins
Credit: Julia Wetherell
For $100 a month, Genspace members have access to the standardized gene sets that are the building blocks of synthetic biology. If that sounds daunting, consider this: Non-scientists make up a big part of...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026